Welcome to the August 2011 edition of the ISPOR eBulletin. The ISPOR eBulletin provides updates of recent ISPOR events and accomplishments. For more information, see: www.ispor.org.
ISPOR 3rd Latin America Conference
8-10 September, 2011, Hilton Mexico City Reforma
Mexico City, Mexico
|Featuring an inaugural message by José Ángel Córdova Villalobos, MD, Secretary of Health, Ministry of Health, Mexico.
Early hotel reservations recommended. For information, see:
Para información en español, visite: Programa
ISPOR 14th Annual European Congress
5-8 November, 2011 at the Hotel Auditórium Madrid, Madrid, Spain
1700 SUBMISSIONS (22% INCREASE)
ISPOR CONNECTIONS Vol. 17 No 4 July/August 2011 On-Line
ISPOR CONNECTIONS Vol. 17 Issue 4 »
Therapeutic and Diagnostic Device Outcomes Research
ORDER NOW. SPECIAL RATE FOR ISPOR MEMBERS
A primer on the unique characteristics of therapeutic and diagnostic device outcomes research (clinical, economics, and patient-reported outcomes). For ordering information, see: Therapeutic and Diagnostic Device Outcomes Research »
ISPOR Performance-Based Risk-Sharing Arrangements Task Force (PBRSA TF)
ISPOR’s Performance-Based Risk-Sharing Arrangements Task Force (PBRSA TF) is looking for Review Group members. For more information on this Task Force, see:
ISPOR Performance-Based Risk-Sharing Arrangements Task Force »
To join the PBRSA TF Review Group, please email firstname.lastname@example.org
ISPOR ePRO Systems Validation Task Force (ePRO SV TF)
ISPOR’s ePRO Systems Validation Task Force is looking for
Review Group members. For more information on this Task Force, see: ISPOR ePRO Systems Validation Task Force » To join the ePRO SV Review Group, email: email@example.com
ISPOR Central America and the Caribbean Regional Chapter
ISPOR is proud to announce the establishment of the ISPOR Central America and the Caribbean Chapters, which will work in conjunction with other chapters in the region to foster the development of pharmacoeconomics and outcomes research. To learn more about this group, see: ISPOR Central America and the Caribbean Regional Chapters »
ISPOR Egypt Regional Chapter
ISPOR announces the formation of the ISPOR Egypt Chapter, located in Cairo, with Mahmoud Elmahdawy, PharmD, as Chapter President. For more information, see: ISPOR Egypt Regional Chapter »
ISPOR New Zealand Regional Chapter
ISPOR announces the formation of the ISPOR New Zealand Chapter. Richard Milne, PhD will serve as Chapter President.
For more information, see: ISPOR New Zealand Regional Chapter »
ISPOR Singapore Regional Chapter First Stakeholders Round Table Discussion
The ISPOR Singapore Chapter will host its First Stakeholders Round Table Discussion on how each stakeholder may contribute to a cost-effective management of health technologies in Singapore on August 24, 2011, Singapore. For program details, see: ISPOR Singapore Regional Chapter »
ISPOR India-Manipal Regional Chapter National Seminar
The ISPOR India-Manipal Chapter organized a national seminar entitled “National Workshop on Community Pharmacists & Patient Healthcare: An International Perspective” and “Pharmacoeconomics and Pharmacovigilance: An Emerging Opportunities in India” on 11 and 12 June 2011 at Manipal College of Pharmaceutical Sciences (MCOPS), India. For seminar information, see: ISPOR lndia-Manipal Regional Chapter »
ISPOR Meetings Page
ISPOR holds its International, European, and Regional Meetings tri-annually in the United States, Europe, Latin America and in the Asia-Pacific rim. To view past and upcoming meetings, go to the Meetings tab on the purple tool bar on the ISPOR homepage, and select Meetings.
Health Economics, Technology Assessment and Market Access
A course by the European School of Health Economics
February 20-24, March 19-23, April 16-19, 2012
The European School of Health Economics launches a modified version of its well-established 3-week course “Health Economics of Pharmaceuticals and other Medical Interventions”. The new course is modular where each week can also be taken alone. Key sessions and case studies run double-track for pharmaceuticals and medical devices.
- Week 1 Economics of health care, health policy, health technology assessment, market access in key regions and markets, pricing in a global environment, decision making in health care, overview of the methods for economic evaluation. Target audience: professionals involved in market access, pricing, regulatory issues, clinical research, project management and outcomes research.
- Week 2 Health economics methodology: Cost of illness studies, costs, outcomes, cost-effectiveness/cost-utility analysis, decision making with economic evaluation, modeling and statistics. Target audience: professionals working in outcomes research in industry or academia, reimbursement organizations or health technology assessment groups.
- Week 3 (4 days) Modeling using TreeAge and Excel. Target audience: professionals working in outcomes research in industry or academia, reimbursement organizations or health technology assessment groups wishing to better understand modeling or involved in creating economic models.
For further information, contact: Information firstname.lastname@example.org